Learn More
  • Birgit Hecht
  • 2010
Orally disposable drugs for the treatment of multiple sclerosis have been research topics for long-term. Actually there are several drugs in clinical trial. Their mode of action differs among themselves and from established therapeutic agents. While cladribine acts as an antimetabolite and reduces lymphocytopoiesis, fingolimod influences circulation of(More)
  • 1